News

Ten new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications

Public consultation on updated policy to run until 10 November 2024

European medicines agencies network strategy to 2028 – launch of public consultation

Board elects new vice-chair and endorses draft network strategy to 2028 for public consultation

Review of medicines containing finasteride and dutasteride started

Measures to optimise use of the EU's expert resources for faster assessments

Measure taken as precaution while review of emerging data is ongoing

8 new medicines recommended for approval; another 12 medicines recommended for extension of their therapeutic indications